Which medications commonly cause a pruritic skin rash?

Common Medications Causing Pruritic Skin Rash

The most common drug classes causing pruritic skin rashes are antibiotics (especially beta-lactams), NSAIDs, opioids, antimalarials (chloroquine), EGFR inhibitors/targeted cancer therapies, and ACE inhibitors 1, 2.

High-Risk Drug Categories

Antibiotics

• Beta-lactam antibiotics are the most frequent cause of IgE-mediated allergic drug reactions presenting with urticaria and pruritic rashes 3
• Topical antibiotics can also cause localized urticaria that may progress to generalized reactions 3

NSAIDs and Aspirin

• Cause acute urticaria and exacerbation of chronic urticaria through pharmacological mechanisms involving arachidonic acid metabolism (not IgE-mediated) 3
• Among the most frequently implicated drugs in cutaneous adverse drug reactions 1

Opioids

• Induce pruritus by directly activating mast cells without requiring IgE antibodies 3
• Can cause generalized pruritus without visible skin lesions 4
• First-line treatment: naltrexone if opioid cannot be discontinued 4

Antimalarials

• Chloroquine specifically causes generalized pruritus without visible skin signs 4
• Treatment options include prednisolone 10 mg, niacin 50 mg, or their combination; dapsone may also relieve itch 4

Cancer Therapies (EGFR Inhibitors and Immune Checkpoint Inhibitors)

• EGFR-TKIs cause skin toxicity in >50% of patients, manifesting as acneiform rash, xerosis, and pruritus 5
• Eruptions concentrate in seborrheic areas (scalp, face, neck, chest, upper back) and typically begin within 1 week of treatment 5
• Immune checkpoint inhibitors (PD-1/PD-L1 inhibitors) are immunogenic and capable of triggering hypersensitivity reactions 5
• Management includes H1-antihistamines or gabapentin for pruritus; prophylactic NSAIDs, minocycline, or doxycycline may prevent EGFR-TKI rash 5

ACE Inhibitors

• Commonly cause angioedema through bradykinin-mediated mechanisms 2, 3

Other Notable Agents

• Antiepileptics are frequently implicated in cutaneous adverse drug reactions 1, 2
• Contrast media ranks among top candidates for drug-induced pruritus 6
• Ophthalmic drugs and dermatological preparations also show high association with pruritus 6

Clinical Approach

Key Diagnostic Features

The diagnosis relies on:

• Temporal relationship: Most drug-induced rashes occur within days to 1-2 weeks of drug initiation
• Morphology patterns: Maculopapular rash and urticaria/angioedema are most common 1
• Distribution: EGFR inhibitors spare periorbital region, palms, and soles 5

Management Algorithm

1. First action: Trial cessation of suspected medication if risk-benefit analysis is acceptable 4

   • Exception: Cancer therapies where treatment interruption may compromise survival

2. For pruritus management when drug cannot be stopped:

   • Opioids: Naltrexone (first-line) or methylnaltrexone 4
   • Chloroquine: Prednisolone 10 mg ± niacin 50 mg, or dapsone 4
   • EGFR inhibitors: H1-antihistamines or gabapentin; topical/systemic corticosteroids 5

3. Immediate discontinuation required if:

   • Bullous or exfoliative skin rash develops (concern for SJS/TEN) 5
   • Grade 4 reactions occur 5

Critical Pitfalls

• Do not assume all drug-induced pruritus is histamine-mediated: NSAIDs work through arachidonic acid pathways, opioids through direct mast cell activation, and ACE inhibitors through bradykinin 3
• Antihistamines are generally ineffective for solid tumor-associated pruritus 4
• Long-term sedating antihistamines may predispose to dementia and should be avoided except in palliative care 4
• Cancer therapy rashes, while not life-threatening, significantly impact quality of life and may lead to dose reduction compromising cancer treatment efficacy 7